1. Home
  2. HOWL vs YSXT Comparison

HOWL vs YSXT Comparison

Compare HOWL & YSXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HOWL
  • YSXT
  • Stock Information
  • Founded
  • HOWL 2017
  • YSXT 2011
  • Country
  • HOWL United States
  • YSXT China
  • Employees
  • HOWL N/A
  • YSXT N/A
  • Industry
  • HOWL Biotechnology: Pharmaceutical Preparations
  • YSXT Automotive Aftermarket
  • Sector
  • HOWL Health Care
  • YSXT Consumer Discretionary
  • Exchange
  • HOWL Nasdaq
  • YSXT Nasdaq
  • Market Cap
  • HOWL 87.4M
  • YSXT 87.9M
  • IPO Year
  • HOWL 2021
  • YSXT 2024
  • Fundamental
  • Price
  • HOWL $1.36
  • YSXT $2.60
  • Analyst Decision
  • HOWL Strong Buy
  • YSXT
  • Analyst Count
  • HOWL 2
  • YSXT 0
  • Target Price
  • HOWL $9.50
  • YSXT N/A
  • AVG Volume (30 Days)
  • HOWL 263.3K
  • YSXT 74.7K
  • Earning Date
  • HOWL 03-06-2025
  • YSXT 01-01-0001
  • Dividend Yield
  • HOWL N/A
  • YSXT N/A
  • EPS Growth
  • HOWL N/A
  • YSXT N/A
  • EPS
  • HOWL N/A
  • YSXT 0.21
  • Revenue
  • HOWL $3,386,000.00
  • YSXT $58,546,729.00
  • Revenue This Year
  • HOWL N/A
  • YSXT N/A
  • Revenue Next Year
  • HOWL $34.17
  • YSXT N/A
  • P/E Ratio
  • HOWL N/A
  • YSXT $11.08
  • Revenue Growth
  • HOWL N/A
  • YSXT 18.92
  • 52 Week Low
  • HOWL $1.26
  • YSXT $2.06
  • 52 Week High
  • HOWL $8.19
  • YSXT $6.27
  • Technical
  • Relative Strength Index (RSI)
  • HOWL 41.40
  • YSXT N/A
  • Support Level
  • HOWL $1.26
  • YSXT N/A
  • Resistance Level
  • HOWL $1.45
  • YSXT N/A
  • Average True Range (ATR)
  • HOWL 0.09
  • YSXT 0.00
  • MACD
  • HOWL 0.02
  • YSXT 0.00
  • Stochastic Oscillator
  • HOWL 45.45
  • YSXT 0.00

About HOWL Werewolf Therapeutics Inc.

Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It is leveraging its proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Its INDUKINE molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment or TME.

About YSXT YSX Tech. Co. Ltd Class A Ordinary Shares

YSX Tech Co Ltd provide business solutions to enterprise customers, mainly insurance companies and brokerages, in China. The company has three operating segments: Auto Insurance Aftermarket Value-added Services, Other Scenario-based Customized Services and Software Development and Information Technology Services. Key revenue is generated from Auto Insurance Aftermarket Value-added Services segment which include four types value added services: vehicle safety inspection and check services, vehicle driving risk screening services, designated driver and rescue services and vehicle maintenance and other value-added services.

Share on Social Networks: